|
|
|
|
||||
|
||||
All that is Gold Does Not Glitter in Human Clinical Research: A Law-Policy Proposal to Brighten the Global 'Gold Standard' for Drug Research and DevelopmentMichael J. MalinowskiLouisiana State University, Baton Rouge - Paul M. Hebert Law Center Grant G. Gautreauxaffiliation not provided to SSRN November 10, 2012 Cornell International Law Journal, Vol. 45, No. 185, 2012 Abstract: This Article challenges the global science standard for putting new drugs on pharmacy shelves. The primary premise is that the “gold standard” of group experimental design is an antiquated extension of drug development's crude-science past, and is inconsistent with the precision of contemporary genetics - the science that increasingly dominates the drug development pipeline. The Article identifies law-policy options that would raise the standard for human clinical research under the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
Number of Pages in PDF File: 20 Accepted Paper SeriesDate posted: November 12, 2012Suggested CitationContact Information
|
|
||||||||||||||||
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
FAQ
Terms of Use
Privacy Policy
Copyright
This page was processed by apollo2 in 0.453 seconds
